Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$0.68 - $1.25 $3,089 - $5,678
4,543 Added 2.03%
228,251 $162,000
Q4 2022

Feb 10, 2023

BUY
$0.96 - $1.34 $5,976 - $8,341
6,225 Added 2.86%
223,708 $230,000
Q3 2022

Nov 14, 2022

BUY
$1.02 - $2.23 $3,132 - $6,848
3,071 Added 1.43%
217,483 $287,000
Q2 2022

Aug 12, 2022

SELL
$0.94 - $1.94 $175 - $362
-187 Reduced 0.09%
214,412 $221,000
Q1 2022

May 13, 2022

SELL
$1.54 - $3.71 $23,261 - $56,039
-15,105 Reduced 6.58%
214,599 $423,000
Q4 2021

Feb 11, 2022

SELL
$2.58 - $3.91 $17,732 - $26,873
-6,873 Reduced 2.91%
229,704 $613,000
Q3 2021

Nov 12, 2021

BUY
$2.77 - $4.05 $10,556 - $15,434
3,811 Added 1.64%
236,577 $802,000
Q2 2021

Aug 13, 2021

BUY
$1.71 - $4.14 $398,029 - $963,651
232,766 New
232,766 $894,000
Q2 2020

Aug 12, 2020

SELL
$0.39 - $0.69 $28,272 - $50,020
-72,494 Closed
0 $0
Q1 2020

May 04, 2020

SELL
$0.56 - $1.62 $2,344 - $6,782
-4,187 Reduced 5.46%
72,494 $46,000
Q4 2019

Feb 05, 2020

SELL
$0.83 - $1.3 $537 - $841
-647 Reduced 0.84%
76,681 $70,000
Q3 2019

Nov 08, 2019

BUY
$0.97 - $1.94 $9,203 - $18,406
9,488 Added 13.99%
77,328 $76,000
Q2 2019

Aug 13, 2019

BUY
$1.81 - $2.45 $24,431 - $33,070
13,498 Added 24.84%
67,840 $138,000
Q1 2019

May 06, 2019

SELL
$2.3 - $3.27 $4,050 - $5,758
-1,761 Reduced 3.14%
54,342 $133,000
Q4 2018

Feb 13, 2019

SELL
$2.49 - $4.54 $1,073 - $1,956
-431 Reduced 0.76%
56,103 $145,000
Q3 2018

Nov 09, 2018

BUY
$3.4 - $4.84 $44,866 - $63,868
13,196 Added 30.45%
56,534 $270,000
Q2 2018

Aug 08, 2018

BUY
$3.03 - $4.98 $131,314 - $215,823
43,338 New
43,338 $178,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $526M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.